Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ji A Sohn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Nucleic Acids|December 17, 2014
Targeting Hepatitis B Virus With CRISPR/Cas9Christoph Seeger, Ji A Sohn
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2016
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNAChristoph Seeger, Ji A Sohn
Journal of Virology|October 20, 2017
Distribution of Hepatitis B Virus Nuclear DNAMingming Li, Ji A Sohn, Christoph Seeger
Plos One|December 4, 2009
Mechanism for CCC DNA synthesis in hepadnavirusesJi A Sohn, Samuel Litwin, Christoph Seeger
Virology|July 3, 2004
Mechanism of the interferon alpha response against hepatitis C virus repliconsJu-Tao Guo, Ji A Sohn, Qing Zhu, et al.
Viral Immunology|August 12, 2011
West Nile virus infection induces depletion of IFNAR1 protein levelsJared D Evans, Rachel A Crown, Ji A Sohn, et al.
Plos One|August 19, 2009
Focal distribution of hepatitis C virus RNA in infected liversJ David Stiffler, Minhhuyen Nguyen, Ji A Sohn, et al.
Plos One|June 17, 2015
Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?Xiuji Cui, Rebecca McAllister, Rajeev Boregowda, et al.
British Journal of Cancer|September 24, 2020
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinomaPeter Makhov, Ji A Sohn, Ilya G Serebriiskii, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Nucleic Acids|December 17, 2014
Targeting Hepatitis B Virus With CRISPR/Cas9Christoph Seeger, Ji A Sohn
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 21, 2016
Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNAChristoph Seeger, Ji A Sohn
Journal of Virology|October 20, 2017
Distribution of Hepatitis B Virus Nuclear DNAMingming Li, Ji A Sohn, Christoph Seeger
Plos One|December 4, 2009
Mechanism for CCC DNA synthesis in hepadnavirusesJi A Sohn, Samuel Litwin, Christoph Seeger
Virology|July 3, 2004
Mechanism of the interferon alpha response against hepatitis C virus repliconsJu-Tao Guo, Ji A Sohn, Qing Zhu, et al.
Viral Immunology|August 12, 2011
West Nile virus infection induces depletion of IFNAR1 protein levelsJared D Evans, Rachel A Crown, Ji A Sohn, et al.
Plos One|August 19, 2009
Focal distribution of hepatitis C virus RNA in infected liversJ David Stiffler, Minhhuyen Nguyen, Ji A Sohn, et al.
Plos One|June 17, 2015
Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?Xiuji Cui, Rebecca McAllister, Rajeev Boregowda, et al.
British Journal of Cancer|September 24, 2020
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinomaPeter Makhov, Ji A Sohn, Ilya G Serebriiskii, et al.
Pageof 1